Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.51 |
| ▸ | SSTR4 | P31391 | 3/20 | 0.44 |
| ▸ | PTPN1 | P18031 | 9/20 | 0.44 |
| ▸ | CDC25B | P30305 | 7/20 | 0.44 |
| ▸ | PTPN2 | P17706 | 5/20 | 0.44 |
| ▸ | PTPN11 | Q06124 | 5/20 | 0.44 |
| ▸ | PTPN6 | P29350 | 4/20 | 0.44 |
| ▸ | GJA1 | P17302 | 1/20 | 0.43 |
| ▸ | GJB2 | P29033 | 1/20 | 0.43 |
| ▸ | SSTR5 | P35346 | 1/20 | 0.40 |
| ▸ | TACR2 | P21452 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23603323 | 0.93 | SSTR4 (0.50) | NT5ESSTR4GJA1GJB2SSTR5 | |
| SCHEMBL23603324 | 0.93 | SSTR4 (0.50) | NT5ESSTR4GJA1GJB2SSTR5 | |
| SCHEMBL23603480 | 0.93 | NT5E (0.47) | NT5ESSTR4PTPN1CDC25BPTPN2 | |
| SCHEMBL23603383 | 0.93 | NT5E (0.47) | NT5ESSTR4PTPN1CDC25BPTPN2 | |
| SCHEMBL23603977 | 0.93 | NT5E (0.47) | NT5ESSTR4PTPN1CDC25BPTPN2 | |
| SCHEMBL23603950 | 0.93 | NT5E (0.47) | NT5ESSTR4PTPN1CDC25BPTPN2 | |
| SCHEMBL23603385 | 0.93 | NT5E (0.47) | NT5ESSTR4PTPN1CDC25BPTPN2 | |
| SCHEMBL24696311 | 0.93 | NT5E (0.47) | NT5ESSTR4PTPN1CDC25BPTPN2 | |
| SCHEMBL23603952 | 0.93 | NT5E (0.47) | NT5ESSTR4PTPN1CDC25BPTPN2 | |
| SCHEMBL23603482 | 0.93 | NT5E (0.47) | NT5ESSTR4PTPN1CDC25BPTPN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11479574-B2 | Vaccine against Klebsiella pneumoniae | IDORSIA PHARMACEUTICALS LTD (CH) | 2022-10-25 | — | — | US | disclosed |
| US-20210198304-A1 | VACCINE AGAINST KLEBSIELLA PNEUMONIAE | IDORSIA PHARMACEUTICALS LTD (CH) | 2021-07-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11479574-B2 | Vaccine against Klebsiella pneumoniae | SLC11A2, OSTC, STT3A | NT5E 3184/4885SSTR4 4041/4885PTPN1 2001/4885 |
| US-20210198304-A1 | VACCINE AGAINST KLEBSIELLA PNEUMONIAE | SLC11A2, OSTC, STT3A | NT5E 3184/4885SSTR4 4041/4885PTPN1 2001/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.